VistaGen Therapeutics, Inc. Uncategorized Contracts & Agreements

21 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Capital Stock of Vistagen Therapeutics, Inc.
Stock Agreements
VistaGen Therapeutics, Inc.
Biotechnology
NV
2024
Exclusive Negotiation Agreement between Vistagen Therapeutics, Inc. and Fuji Pharma Co., Ltd. (September 1, 2023)
Collaboration Agreements
VistaGen Therapeutics, Inc.
Biotechnology
CA
2023
Open Market Sale Agreement between VistaGen Therapeutics, Inc. and Jefferies LLC (May 14, 2021)
Underwriting Agreements
VistaGen Therapeutics, Inc.
Biotechnology
NY
2021
Option Agreement between Pherin Pharmaceuticals, Inc. and VistaGen Therapeutics, Inc. for Exclusive License Rights
VistaGen Therapeutics, Inc.
Biotechnology
CA
2018
Exclusive License and Sublicense Agreement between VistaGen Therapeutics, Inc. and Apollo Biologics LP
License Agreements
VistaGen Therapeutics, Inc.
Biotechnology
DE
2017
Second Amendment to Lease Agreement between Bayside Area Development, LLC and VistaGen Therapeutics, Inc.
Lease Agreements
VistaGen Therapeutics, Inc.
Biotechnology
2016
Underwriting Agreement between VistaGen Therapeutics, Inc. and Chardan Capital Markets, LLC and WallachBeth Capital, LLC
Underwriting Agreements
VistaGen Therapeutics, Inc.
Biotechnology
NY
2016
Acknowledgement and Agreement between VistaGen Therapeutics, Inc. and Platinum Long Term Growth VII, LLC (May 12, 2015)
Modification Agreements
VistaGen Therapeutics, Inc.
Biotechnology
2015
Agreement for Note Conversion, Security Release, and Investment between VistaGen Therapeutics, Inc. and Platinum Long Term Growth VII, LLC (May 5, 2015)
Financing Agreements
VistaGen Therapeutics, Inc.
Biotechnology
NY
2015
Amendment No. 2 to Amended and Restated Note Conversion Agreement and Warrant Amendment between VistaGen Therapeutics, Inc. and Platinum Long Term Growth VII, LLC
Modification Agreements
VistaGen Therapeutics, Inc.
Biotechnology
2014
VistaGen Therapeutics, Inc. Unit Subscription Agreement with Accredited Investors
Subscription Agreements
VistaGen Therapeutics, Inc.
Biotechnology
2014
VistaGen Therapeutics, Inc. Subordinate Convertible Promissory Bridge Note (April 1, 2014)
Note Agreements
VistaGen Therapeutics, Inc.
Biotechnology
NY
2014
Assignment and Assumption Agreement between Autilion AG and Bergamo Acquisition Corp PTE Ltd dated April 12, 2013
Assignment Agreements
VistaGen Therapeutics, Inc.
Biotechnology
2013
Negative Covenant Agreement among Vistagen Therapeutics, Inc., Artemis Neuroscience, Inc., and Platinum Long Term Growth VII LLC (2012)
VistaGen Therapeutics, Inc.
Biotechnology
CA
2012
CIRM Grant Award Notice to VistaGen Therapeutics, Inc. for hES Cell-Based Assay System Project
Funding Agreements
VistaGen Therapeutics, Inc.
Biotechnology
2011
NIH Grant Award to VistaGen Therapeutics, Inc. for Clinical Development of 4-Cl-KYN to Treat Pain
Funding Agreements
VistaGen Therapeutics, Inc.
Biotechnology
2011
VistaGen Therapeutics, Inc. Conversion Agreement with Note Holders (April 29, 2011)
VistaGen Therapeutics, Inc.
Biotechnology
CA
2011
Clinical Study Agreement between VistaGen Therapeutics, Inc. and Progressive Medical Concepts, LLC for Phase 1 AV-101 Study
Services Agreements
VistaGen Therapeutics, Inc.
Biotechnology
CA
2011
VistaGen Therapeutics, Inc. Subscription Agreement for Units (May 11, 2011)
Subscription Agreements
VistaGen Therapeutics, Inc.
Biotechnology
2011
Securities Purchase Agreement between VistaGen Therapeutics, Inc. and Platinum Long Term Growth VII, LLC (November 5, 2009)
Purchase Agreements
VistaGen Therapeutics, Inc.
Biotechnology
CA
2011
VistaGen Therapeutics, Inc. 2008 Stock Incentive Plan Stock Option Award Agreement with Grantee
Warrant Agreements
VistaGen Therapeutics, Inc.
Biotechnology
CA
2011